Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.02M Buy
7,919
+2,829
+56% +$331K 0.11% 127
2026
Q1
$612K Buy
5,090
+850
+20% +$98.1K 0.2% 95
2025
Q4
$446K Buy
4,240
+228
+6% +$21.4K 0.12% 114
2025
Q3
$337K Sell
4,012
-26
-0.6% -$2.14K 0.12% 128
2025
Q2
$320K Sell
4,038
-184
-4% -$14.6K 0.12% 129
2025
Q1
$379K Buy
+4,222
New +$394K 0.17% 103
2024
Q4
Sell
-4,681
Closed -$532K 118
2024
Q3
$532K Buy
+4,681
New +$556K 0.29% 67

Other funds holding MRK

Elyxium Wealth's MRK Position: Q2 2026 in Review

Elyxium Wealth increased its Merck (MRK) stake by 56% in Q2 2026, buying an estimated $331K and bringing the position to 7,919 shares worth $1.02M. The position accounts for 0.11% of the portfolio, ranked #127.

Elyxium Wealth first reported a position in MRK in Q3 2024 and has held it in 7 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Elyxium Wealth held 7,919 shares of Merck worth $1.02M as of Q2 2026.
  • Elyxium Wealth bought 2,829 Merck shares in Q2 2026, an estimated $331K.
  • Merck made up 0.11% of Elyxium Wealth's portfolio in Q2 2026, its #127 holding.
  • Elyxium Wealth first reported a position in Merck in Q3 2024 and has held it in 7 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Elyxium Wealth's 13F filing for Q2 2026, filed 3 Aug 2026.